IL217502A0 - Potent small molecule inhibitors of autophagy, and methods of use thereof - Google Patents
Potent small molecule inhibitors of autophagy, and methods of use thereofInfo
- Publication number
- IL217502A0 IL217502A0 IL217502A IL21750212A IL217502A0 IL 217502 A0 IL217502 A0 IL 217502A0 IL 217502 A IL217502 A IL 217502A IL 21750212 A IL21750212 A IL 21750212A IL 217502 A0 IL217502 A0 IL 217502A0
- Authority
- IL
- Israel
- Prior art keywords
- autophagy
- methods
- small molecule
- molecule inhibitors
- potent small
- Prior art date
Links
- 230000004900 autophagic degradation Effects 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 230000003389 potentiating effect Effects 0.000 title 1
- 150000003384 small molecules Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/94—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/88—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/93—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Oncology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Communicable Diseases (AREA)
- Biomedical Technology (AREA)
- Hospice & Palliative Care (AREA)
- Rheumatology (AREA)
- Virology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Hematology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US22716409P | 2009-07-21 | 2009-07-21 | |
| US29673510P | 2010-01-20 | 2010-01-20 | |
| PCT/US2010/042759 WO2011011522A2 (en) | 2009-07-21 | 2010-07-21 | Potent small molecule inhibitors of autophagy, and methods of use thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL217502A0 true IL217502A0 (en) | 2012-02-29 |
Family
ID=42829077
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL217502A IL217502A0 (en) | 2009-07-21 | 2012-01-12 | Potent small molecule inhibitors of autophagy, and methods of use thereof |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US20120258975A1 (OSRAM) |
| EP (1) | EP2456761A2 (OSRAM) |
| JP (1) | JP2013500255A (OSRAM) |
| KR (1) | KR20120100886A (OSRAM) |
| CN (1) | CN102574816A (OSRAM) |
| AU (1) | AU2010276223A1 (OSRAM) |
| BR (1) | BR112012001316A2 (OSRAM) |
| CA (1) | CA2767772A1 (OSRAM) |
| CL (1) | CL2012000163A1 (OSRAM) |
| IL (1) | IL217502A0 (OSRAM) |
| IN (1) | IN2012DN01478A (OSRAM) |
| MX (1) | MX2012000940A (OSRAM) |
| PE (1) | PE20120798A1 (OSRAM) |
| PH (1) | PH12012500097A1 (OSRAM) |
| RU (1) | RU2012105914A (OSRAM) |
| SG (1) | SG177486A1 (OSRAM) |
| WO (1) | WO2011011522A2 (OSRAM) |
| ZA (1) | ZA201201224B (OSRAM) |
Families Citing this family (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2013504586A (ja) | 2009-09-10 | 2013-02-07 | メイヨ・ファウンデーション・フォー・メディカル・エデュケーション・アンド・リサーチ | 脱ユビキチン化酵素およびユビキチン化ポリペプチドを調節するための方法および材料 |
| US8598344B2 (en) * | 2009-11-30 | 2013-12-03 | Senex Biotechnology | CDKI pathway inhibitors and uses thereof |
| EA023998B1 (ru) | 2011-03-04 | 2016-08-31 | Глэксосмитклайн Интеллекчуал Проперти Дивелопмент Лимитед | Аминохинолины в качестве ингибиторов киназ |
| TWI547494B (zh) | 2011-08-18 | 2016-09-01 | 葛蘭素史克智慧財產發展有限公司 | 作為激酶抑制劑之胺基喹唑啉類 |
| EA027531B1 (ru) * | 2011-09-13 | 2017-08-31 | Игорь Ронинсон | ЛЕЧЕНИЕ ЗАБОЛЕВАНИЙ И НАРУШЕНИЙ, ВЫЗВАННЫХ АКТИВНОСТЬЮ ТРАНСКРИПЦИОННОГО ФАКТОРА NF-κB |
| TWI592417B (zh) | 2012-09-13 | 2017-07-21 | 葛蘭素史克智慧財產發展有限公司 | 胺基喹唑啉激酶抑制劑之前藥 |
| JP2016504365A (ja) * | 2012-12-28 | 2016-02-12 | アメリカ合衆国 | Ｕｓｐ１／ｕａｆ１デユビキチナーゼ複合体阻害剤及びその使用 |
| ES2790675T3 (es) | 2013-02-01 | 2020-10-28 | Wellstat Therapeutics Corp | Compuestos de amina que tienen actividad anti-inflamatoria, antifúngica, antiparasitaria y anticáncer |
| TWI630203B (zh) | 2013-02-21 | 2018-07-21 | 葛蘭素史克智慧財產發展有限公司 | 做為激酶抑制劑的喹唑啉類 |
| EP2961409A1 (en) * | 2013-02-26 | 2016-01-06 | Senex Biotechnology, Inc. | Inhibitors of cdk8/19 for use in treating estrogen receptor positive breast cancer |
| WO2014145512A2 (en) * | 2013-03-15 | 2014-09-18 | President And Fellows Of Harvard College | Potent small molecule inhibitors of autophagy, and methods of use thereof |
| JP2016517439A (ja) * | 2013-03-15 | 2016-06-16 | ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー | 医学的状態の治療のためのクロマチン修飾因子の標的化 |
| US9393244B2 (en) | 2013-03-15 | 2016-07-19 | Georgetown University | Increasing parkin activity by administering a deubiquitinating enzyme inhibitor |
| US11306328B2 (en) * | 2013-07-26 | 2022-04-19 | President And Fellows Of Harvard College | Genome engineering |
| CN104164471A (zh) * | 2013-11-04 | 2014-11-26 | 复旦大学 | 基于细胞自噬的抗肿瘤药物的筛选方法 |
| WO2016182812A1 (en) * | 2015-05-08 | 2016-11-17 | The Board Of Regents Of The University Of Texas System | Activation of neuronal store-operated calcium entry pathway for the treatment of alzheimer's disease |
| BR112018006873A2 (pt) * | 2015-10-05 | 2018-11-06 | The Trustees Of Columbia University In The City Of New York | ativadores do fluxo autofágico e fosfolipase d e depuração de agregados de proteína incluindo tau e tratamento de proteinopatias |
| EP3184514A1 (en) * | 2015-12-23 | 2017-06-28 | Deutsches Krebsforschungszentrum | Autophagy inhibitors |
| GB201700814D0 (en) * | 2017-01-17 | 2017-03-01 | Liverpool School Tropical Medicine | Compounds |
| CN108929373A (zh) * | 2017-05-22 | 2018-12-04 | 苏州偶领生物医药有限公司 | 一种共价键修饰哺乳动物atg8 同源物的方法 |
| WO2020021064A1 (en) | 2018-07-26 | 2020-01-30 | Domain Therapeutics | Substituted quinazolinone derivatives and their use as positive allosteric modulators of mglur4 |
| CN109721554A (zh) * | 2019-01-08 | 2019-05-07 | 贵州大学 | 一类4-氨基喹唑啉类化合物及其制备方法和应用 |
| HUE065486T2 (hu) | 2019-05-10 | 2024-05-28 | Deciphera Pharmaceuticals Llc | Fenilaminopirimidinamid autophágia inhibitorok és azok felhasználási eljárásai |
| PE20220592A1 (es) | 2019-05-10 | 2022-04-22 | Deciphera Pharmaceuticals Llc | Inhibidores de la autofagia de heteroarilaminopirimidina amida y metodos de uso de estos |
| CA3143489A1 (en) | 2019-06-17 | 2020-12-24 | Deciphera Pharmaceuticals, Llc | Aminopyrimidine amide autophagy inhibitors and methods of use thereof |
| US20210215710A1 (en) * | 2019-12-23 | 2021-07-15 | University Health Network | Methods for use of cdx2 as a biomarker to guide use of autophagy inhibitors in ovarian cancer |
| EP4114946A1 (en) | 2020-03-04 | 2023-01-11 | Regeneron Pharmaceuticals, Inc. | Methods and compositions for sensitization of tumor cells to immune therapy |
| CN112608302B (zh) * | 2020-12-28 | 2022-05-24 | 郑州大学第一附属医院 | 低氧还原激活靶向泛素化降解egfr蛋白的喹唑啉类衍生物及其应用 |
| US20240092800A1 (en) * | 2021-01-14 | 2024-03-21 | Georgetown University | Usp13 inhibitors and methods of use thereof |
| WO2022187411A1 (en) * | 2021-03-02 | 2022-09-09 | Kumquat Biosciences Inc. | Heterocycles and uses thereof |
| EP4395549A1 (en) | 2021-09-01 | 2024-07-10 | Oerth Bio LLC | Compositions and methods for targeted degradation of proteins in a plant cell |
| CN114224895B (zh) * | 2022-01-06 | 2023-06-30 | 山东农业大学 | 3-甲基腺嘌呤在清除牛乳腺上皮细胞内无乳链球菌中的应用 |
| JP2025515285A (ja) | 2022-04-20 | 2025-05-14 | カムクワット バイオサイエンシーズ インコーポレイテッド | 大環状複素環及びその使用 |
| CN116179494B (zh) * | 2022-10-13 | 2024-01-26 | 武汉生物制品研究所有限责任公司 | 低成瘤性的mdck细胞株及其构建方法和应用 |
| DE102022131212A1 (de) | 2022-11-25 | 2024-05-29 | Dr. Ing. H.C. F. Porsche Aktiengesellschaft | Luftzufuhrvorrichtung einer Kraftfahrzeugkarosserie eines Kraftfahrzeugs |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS542327A (en) * | 1977-06-07 | 1979-01-09 | Sankyo Co Ltd | Agricultural and horticultural pesticide |
| JPS542325A (en) * | 1977-06-07 | 1979-01-09 | Sankyo Co Ltd | Agricultural and horticultural pesticide |
| GT198900008A (es) * | 1988-01-29 | 1990-07-17 | Derivados de quinolina, quinazolina y cinolina. | |
| IL89027A (en) * | 1988-01-29 | 1993-01-31 | Lilly Co Eli | Quinazoline derivatives, process for their preparation and fungicidal, insecticidal and miticidal compositions containing them |
| US5034393A (en) * | 1989-07-27 | 1991-07-23 | Dowelanco | Fungicidal use of pyridopyrimidine, pteridine, pyrimidopyrimidine, pyrimidopyridazine, and pyrimido-1,2,4-triazine derivatives |
| US5227387A (en) * | 1991-09-03 | 1993-07-13 | Dowelanco | Quinoline nematicidal method |
| PT100905A (pt) * | 1991-09-30 | 1994-02-28 | Eisai Co Ltd | Compostos heterociclicos azotados biciclicos contendo aneis de benzeno, ciclo-hexano ou piridina e de pirimidina, piridina ou imidazol substituidos e composicoes farmaceuticas que os contem |
| US6262059B1 (en) * | 1995-06-07 | 2001-07-17 | Cell Pathways, Inc. | Method of treating a patient having precancerous lesions with quinazoline derivatives |
| US6046206A (en) * | 1995-06-07 | 2000-04-04 | Cell Pathways, Inc. | Method of treating a patient having a precancerous lesions with amide quinazoline derivatives |
| DE10042060A1 (de) * | 2000-08-26 | 2002-03-07 | Boehringer Ingelheim Pharma | Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung |
| EP1481971B1 (en) * | 2002-02-06 | 2011-11-16 | Ube Industries, Ltd. | Process for producing 4-aminoquinazoline compound |
| JP2004059454A (ja) * | 2002-07-25 | 2004-02-26 | Japan Energy Corp | キナゾリン誘導体及びＮＦ−κＢ活性化阻害剤 |
| JP4934432B2 (ja) * | 2004-02-19 | 2012-05-16 | レクサン ファーマシューティカルズ インコーポレイテッド | キナゾリン誘導体およびキナゾリン誘導体の治療への使用 |
| JP2008526734A (ja) * | 2004-12-31 | 2008-07-24 | エスケー ケミカルズ カンパニー リミテッド | 糖尿及び肥満治療予防に有効なキナゾリン誘導体 |
| EP1856247B1 (en) | 2005-01-19 | 2016-05-04 | The Trustees of The University of Pennsylvania | Regulation of autophagy and cell survival |
| WO2008122038A1 (en) * | 2007-04-02 | 2008-10-09 | President And Fellows Of Harvard College | Regulating autophagy |
| US8039502B2 (en) | 2007-07-24 | 2011-10-18 | The Ohio State University Research Foundation | Anti-infective agents against intracellular pathogens |
-
2010
- 2010-01-13 PH PH12012500097A patent/PH12012500097A1/en unknown
- 2010-07-21 KR KR1020127004431A patent/KR20120100886A/ko not_active Withdrawn
- 2010-07-21 IN IN1478DEN2012 patent/IN2012DN01478A/en unknown
- 2010-07-21 AU AU2010276223A patent/AU2010276223A1/en not_active Abandoned
- 2010-07-21 WO PCT/US2010/042759 patent/WO2011011522A2/en not_active Ceased
- 2010-07-21 BR BR112012001316A patent/BR112012001316A2/pt not_active IP Right Cessation
- 2010-07-21 EP EP10737435A patent/EP2456761A2/en not_active Withdrawn
- 2010-07-21 CN CN2010800332736A patent/CN102574816A/zh active Pending
- 2010-07-21 SG SG2012000253A patent/SG177486A1/en unknown
- 2010-07-21 MX MX2012000940A patent/MX2012000940A/es not_active Application Discontinuation
- 2010-07-21 PE PE2012000085A patent/PE20120798A1/es not_active Application Discontinuation
- 2010-07-21 US US13/382,572 patent/US20120258975A1/en not_active Abandoned
- 2010-07-21 RU RU2012105914/04A patent/RU2012105914A/ru not_active Application Discontinuation
- 2010-07-21 CA CA2767772A patent/CA2767772A1/en not_active Abandoned
- 2010-07-21 JP JP2012521755A patent/JP2013500255A/ja active Pending
-
2012
- 2012-01-12 IL IL217502A patent/IL217502A0/en unknown
- 2012-01-20 CL CL2012000163A patent/CL2012000163A1/es unknown
- 2012-02-17 ZA ZA2012/01224A patent/ZA201201224B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP2456761A2 (en) | 2012-05-30 |
| US20120258975A1 (en) | 2012-10-11 |
| AU2010276223A1 (en) | 2012-03-08 |
| WO2011011522A2 (en) | 2011-01-27 |
| RU2012105914A (ru) | 2013-08-27 |
| CL2012000163A1 (es) | 2012-07-13 |
| PH12012500097A1 (en) | 2011-01-27 |
| ZA201201224B (en) | 2012-10-31 |
| JP2013500255A (ja) | 2013-01-07 |
| IN2012DN01478A (OSRAM) | 2015-06-05 |
| BR112012001316A2 (pt) | 2017-08-08 |
| KR20120100886A (ko) | 2012-09-12 |
| CN102574816A (zh) | 2012-07-11 |
| WO2011011522A3 (en) | 2011-08-25 |
| SG177486A1 (en) | 2012-02-28 |
| MX2012000940A (es) | 2012-05-08 |
| PE20120798A1 (es) | 2012-07-27 |
| CA2767772A1 (en) | 2011-01-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA201201224B (en) | Potent small molecule inhibitors of autophagy,and methods of use thereof | |
| SMT202200371T1 (it) | Determinate triazolopirazine, loro composizioni e loro metodi d'uso | |
| IL210843A0 (en) | Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof | |
| IL214822A0 (en) | Substituted azoanthracene derivatives, pharmaceutical compositions, and methods of use thereof | |
| ZA201203326B (en) | Imidazopyridine derivatives as jak inhibitors | |
| IL215999A0 (en) | Processes for the preparation of rivaroxaban and intermediates thereof | |
| PL2442644T3 (pl) | Ligandy wiążące opsynę, kompozycje i sposoby zastosowania | |
| EP2239261A4 (en) | PYRROLOPYRIMIDINE DERIVATIVE FOR USE AS A PI3K INHIBITOR AND USE THEREOF | |
| EP2416657A4 (en) | COMPOUNDS COMPRISING SUBSTITUTED DI-ARYLHYDANTOIDS AND DI-ARYLTHIOHYDANTOINES AND METHODS OF USE THEREOF | |
| IL236830A0 (en) | Diazahomoredene derivatives and methods of using them | |
| FI20096339L (fi) | Liima-aine, menetelmä sen valmistamiseksi sekä sen käyttö | |
| IL220190A0 (en) | Proteasome inhibitors and processes for their preparation, purification and use | |
| EP2242501A4 (en) | THERAPEUTIC INHIBITORS OF PAI-I FUNCTION AND METHODS OF USE | |
| ZA201308268B (en) | Herbicidal composition comprising pinoxaden and fluroxypyrester, and methods of use thereof | |
| IL214408A0 (en) | Derivatives of 6-(6-substituted-triazolopyidazine-sulfanyl) 5-fluoro-benzothiazoles and 5-fluoro-benzimidazoles, preparation thereof, use thereof as drugs, and use thereof as met inhibitors | |
| EP2424533A4 (en) | SUBSTITUTED ISOQUINOLINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND THEIR METHODS OF USE AS-SECRETASE INHIBITORS | |
| GB0801940D0 (en) | Inhibitors of lentiviral replication | |
| GB2488494B (en) | Solution, use and method of preparation thereof | |
| IL208543A0 (en) | Opiorphin peptide derivatives as potent inhibitors of enkephalin-degrading ectopetidases | |
| IL212700A0 (en) | Novel pyrazolone-derivatives and their use as pd4 inhibitors | |
| ZA201201740B (en) | Process for the preparation of cathepsin s inhibitors | |
| GB0908609D0 (en) | New use of isoQC inhibitors | |
| GB0803895D0 (en) | Inhibitors of glyoxalase | |
| HK1170235A (en) | Process for the preparation of cathepsin s inhibitors | |
| HK1166059A (en) | Heteroaryls and their use as pi3k inhibitors |